证券记录 · 已归档季度
AVTX
Avalo Therapeutics, Inc. · Healthcare · Biotechnology
13被追踪持有人
+7Δ持有人
3.14M持有股份
$39.85M报告持仓市值
+7新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +30.0% ·
股份流向 +30.0% ·
净新建仓位 +20.0%
· 公式
广泛增持：持股数量上升，持有人数量增加
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 51 | +13 | 31.74M | $586.58M | +19 | −6 |
| Q1 2026 | 38 | +3 | 12.35M | $184.22M | +7 | −4 |
| Q4 2025 | 35 | +2 | 8.20M | $148.88M | +2 | n/a |
| Q3 2025 | 13 | +7 | 3.14M | $39.85M | +7 | n/a |
| Q2 2025 | 4 | +1 | 446.19K | $2.23M | +1 | n/a |
| Q1 2025 | 1 | -1 | 107.81K | $864,389 | n/a | −1 |
| Q4 2024 | 2 | +1 | 120.18K | $892,907 | +1 | n/a |
| Q3 2024 | 1 | +1 | 10.11K | $95,649 | +1 | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management ✦ | 1.05M | 新增 | $13.40M | 0.0% | New | 1 | SEC ↗ |
| 2 | The Vanguard Group ✦ (被动) | 692.64K | +314.9% | $8.80M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 3 | Citadel Advisors ✦ | 481.67K | 新增 | $6.12M | 0.0% | New | 1 | SEC ↗ ×2 |
| 4 | Adage Capital Partners ✦ | 258.77K | 新增 | $3.29M | 0.0% | New | 1 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 154.25K | -1.1% | $1.96M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 6 | Millennium Management ✦ | 137.43K | 新增 | $1.75M | 0.0% | New | 1 | SEC ↗ |
| 7 | Geode Capital Management ✦ (被动) | 104.19K | -5.7% | $1.33M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 8 | Renaissance Technologies ✦ | 98.70K | 新增 | $1.25M | 0.0% | New | 1 | SEC ↗ |
| 9 | Marshall Wace ✦ | 56.01K | 新增 | $711,874 | 0.0% | New | 1 | SEC ↗ ×2 |
| 10 | Two Sigma Investments ✦ | 49.24K | +282.1% | $625,866 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | State Street Global Advisors ✦ (被动) | 45.45K | 新增 | $577,720 | 0.0% | New | 1 | SEC ↗ |
| 12 | JPMorgan Chase ✦ | 3.15K | n/a | $39,984 | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 13 | Morgan Stanley ✦ | 10 | n/a | $127 | 0.0% | n/c | 1 | SEC ↗ ×2 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $13.40M | 0.0% |
| Citadel Advisors | $6.12M | 0.0% |
| Adage Capital Partners | $3.29M | 0.0% |
| Millennium Management | $1.75M | 0.0% |
| Renaissance Technologies | $1.25M | 0.0% |
| Marshall Wace | $711,874 | 0.0% |
| State Street Global Advisors | $577,720 | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 96 持有人, 30.91M 股份, $428.51M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Sep 16
Sullivan Christopher Ryan
Officer · 12.39K 股 · $202,437
Sep 10
Sullivan Christopher Ryan
Officer · 10.19K 股 · $179,457
Aug 28
Doyle Mittie
Officer · 679 股 · $13,580
Aug 18
Sullivan Christopher Ryan
Officer · 31.03K 股 · $622,324
Aug 17
Sullivan Christopher Ryan
Officer · 37.95K 股 · $753,333
Aug 17
Sullivan Christopher Ryan
Officer · 3.75K 股 · $74,762
Aug 17
Doyle Mittie
Officer · 1.00K 股 · $20,000
Aug 11
Riley Jennifer
Officer · 2.65K 股 · $52,012
Aug 10
Doyle Mittie
Officer · 679 股 · $13,580
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 14
SC 13G/A: T. Rowe Price Investment Management…
Aug 14
SC 13G/A: Caligan Partners LP
Aug 14
SC 13G/A: RA CAPITAL MANAGEMENT, L.P.
Aug 14
SC 13G/A: Deep Track Capital, LP
Aug 14
SC 13G/A: Nantahala Capital Management, LLC
Aug 14
SC 13G/A: BIOTECHNOLOGY VALUE FUND L P
Aug 14
SC 13G/A: Avoro Capital Advisors LLC
Aug 13
SC 13G/A: Affinity Asset Advisors, LLC
Aug 07
SC 13G/A: FMR LLC
Aug 07
SC 13G: STATE STREET CORP
Aug 06
SC 13G/A: FMR LLC
Jul 27
SC 13G: BlackRock, Inc.
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据